ADAMTS16 and squamous cell carcinoma: In contrast, there was no statistical association of expression of PXDN with survival of squamous cell carcinoma patients, whereas higher expression of ADAMTS16 was significantly associated with shorter survival of squamous cell carcinoma patients (HR = 1.72; 95% CI, 1.18–2.50; P = 0.0043) (Figure 4G).